McCormick & Co (NYSE:MKC) Bolsa

McCormick & Co

In its 135-year history, McCormick has become the leading global manufacturer, marketer, and distributor of spices, herbs, extracts, seasonings, and other flavorings. Beyond consumers, McCormick's customer base includes top quick-service restaurants, retail grocery chains, and other packaged food and beverage manufacturers. And its reach is extensive, with nearly 40% of sales generated beyond its home turf to 150 other countries and territories. In addition to its namesake brand, the firm's portfolio includes Old Bay, Zatarain's, Thai Kitchen, Frank's RedHot, French's, and Cholula, among others.

McCormick & Company, Incorporated Common Stock

McCormick & Co Inc

Medikit Co Ltd

Government health agencies are pushing forward an <a target="_blank" href="https://www.fda.gov/news-events/press-announcements/hhs-fda-phase-out-petroleum-based-synthetic-dyes-nations-food-supply" rel="noreferrer noopener">overhaul of food additive rules</a> to remove petroleum-based artificial dyes from products sold in the U.S.
The effort, revealed on Wednesday, falls under health secretary&nbsp;Robert F. Kennedy Jr's larger "Make America Healthy Again" plan, which seeks to boost national health by tightening dietary guidelines.
The U.S. Food and Drug Administration (FDA) and the Department of Health and Human Services introduced a roadmap outlining the shift toward plant-based food colorings across the industry.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/44909706/tariff-pressures-could-reshape-restaurant-buildout-economics-says-analyst" rel="noreferrer noopener">Tariff Pressures Could Reshape Restaurant Buildout Economics, Says Analyst</a>
"For too long, some food producers have been feeding Americans petroleum-based chemicals without their knowledge or consent," said HHS Secretary Robert F. Kennedy, Jr.
"These poisonous compounds offer no nutritional benefit and pose real, measurable dangers to our children's health and development. That era is coming to an end.
As part of the plan, approvals for two synthetic dyes, Citrus Red No. 2 and Orange B, will be rescinded in the coming months.
Regulators are coordinating with manufacturers to eliminate six commonly used food colorings: FD&amp;C Red No. 40, FD&amp;C Yellow Nos. 5 and 6, FD&amp;C Green No. 3, and FD&amp;C Blue Nos. 1 and 2 by the end of next year.
The FDA also encouraged companies to retire FD&amp;C Red No. 3 ahead of the current 2027-2028 target. To support a seamless shift, the agency intends to authorize four new naturally derived color additives in the near future.
It is also speeding up the evaluation process for substitutes such as butterfly pea flower extract, Galdieria blue, gardenia blue, and calcium phosphate. In addition, updated regulatory guidelines are being developed to assist manufacturers in meeting the new requirements.
In collaboration with the National Institutes of Health (NIH), the FDA will undertake a broad research effort to assess how food dyes influence children's development and well-being.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/health-care/25/04/44952308/boston-scientific-raises-annual-outlook-after-strong-heart-devices-sales-in-q1-announces-cfo-transition" target="_blank" rel="noreferrer noopener">Boston Scientific Raises Annual Outlook After Strong Heart Devices Sales In Q1, Announces CFO Transition</a></li>
</ul>
Photo by Tada Images via Shutterstock

News

General

MDLZ

MNST

FDA Targets Synthetic Food Dyes In Sweeping Nutrition Overhaul

WIIM

ABEV

ANDE

BRBR

BRFS

CART

CASY

CELH

CENT

CENTA

COCO

COKE

COST

COTY

FIZZ

Fomento Economico Mexicano S.A.B. De C.V.

FRPT

HFFG

HNST

IPAR

ISPR

MGPI

PFGC

PSMT

SNYR

TBBB

UNFI

UPXI

USFD

USNA

WALD

WEST

Shares of consumer staple companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

BofA Securities analysts Bryan D. Spillane, Lisa K. Lewandowski and Peter T. Galbo have put forward on Tuesday their research findings on consumer staple companies in the face of a potential recession.
The analysts said consumer staples have historically outperformed the S&amp;P 500 in most recent recessions, suggesting a defensive edge.
However, the analysts warned that current conditions, such as lingering high prices and weak volume growth, may limit their resilience in a future downturn.
Also Read: <a target="_blank" href="https://www.benzinga.com/tech/25/04/44695622/amazon-touts-ai-milestone-says-new-model-outshines-gpt-4o-in-real-time-speech" rel="noreferrer noopener">Amazon Touts AI Milestone, Says New Model Outshines GPT-4o In Real-Time Speech</a>
Still, their limited exposure to new tariffs could make the sector more appealing than others, potentially helping sustain valuation multiples.
During recessions, the Consumer Staples sector stock prices are primarily influenced by earnings per share (EPS) rather than sales growth.
Analysis shows that forward EPS estimates account for over 90% of stock price movement across key subsectors like Beverages, Household &amp; Personal Care (HPC), Packaged Food, and Tobacco, with the correlation being the tightest Beverages and HPC.
The analysts noted that this highlights the critical importance of earnings strength when evaluating stock performance in uncertain economic conditions.
A review of six past recessions reveals that certain Consumer Staples stocks consistently outperformed the S&amp;P 500.
Campbell Soup Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPB#NYSE">CPB</a>), Colgate-Palmolive Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>), General Mills Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIS#NYSE">GIS</a>), McCormick &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>), PepsiCo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>), and Hormel Foods Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HRL#NYSE">HRL</a>) each posted a 100% success rate in outperforming the index during those downturns.
In the last four recessions with the most comprehensive data, McCormick, General Mills, and Church &amp; Dwight Co. Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHD#NYSE">CHD</a>) delivered the strongest relative performance.
Top-performing Consumer Staples stocks in a potential downturn will likely share three traits: profit flexibility to offset revenue pressure and rising costs, strong U.S. manufacturing presence to limit tariff-related inflation, and solid balance sheets capable of sustaining share buybacks to boost earnings per share.
Analysts see McCormick, Coca-Cola Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>) and Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) as well-defended, with Keurig Dr Pepper Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDP#NASDAQ">KDP</a>), Molson Coors Beverage Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>) and Altria Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>) in the next tier of potential outperformers.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/25/04/44685643/whats-going-on-with-rocket-lab-stock-today-4" target="_blank" rel="noreferrer noopener">What&#8217;s Going On With Rocket Lab Stock Today?</a></li>
</ul>
Image via Shutterstock

Analyst Color

Analyst Ratings

Trading Ideas

This Beverage Maker, Tobacco Company And Packaged Food Giant Outshine In A Recession

Looking into the current session, McCormick &amp; Co Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>) shares are trading at $78.53, after a 2.85% decrease. Over the past month, the stock decreased by 4.94%, but over the past year, it actually increased by 3.84%. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2025/1743789625_0.png" alt="Past Year Chart" />

<h3>How Does McCormick &amp; Co P/E Compare to Other Companies?</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of 23.03 in the Food Products industry, McCormick &amp; Co Inc. has a higher P/E ratio of 27.88. Shareholders might be inclined to think that McCormick &amp; Co Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1743789625_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Markets

Price Over Earnings Overview: McCormick & Co

Shares of McCormick &amp; Co Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>) are <a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener">trading lower in premarket</a> on Tuesday after the company reported worse-than-expected first-quarter FY25 earnings.
The company reported<a href="https://www.benzinga.com/pressreleases/25/03/n44470121/mccormick-reports-solid-first-quarter-performance-and-reaffirms-2025-outlook" target="_blank" rel="noreferrer noopener"> first-quarter sales growth</a> of 0.2% year-on-year to $1.605 billion, missing the analyst consensus estimate of $1.612 billion.
Flavor Solutions segment sales increased 1% from the first quarter of 2024 to&nbsp;$686 million, including a 2% unfavorable impact from currency.
Consumer segment sales of&nbsp;$919 million&nbsp;were consistent with the first quarter of 2024 and included a 1% unfavorable impact from currency.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/03/44457612/tilrays-hiball-energy-returns-to-whole-foods-market-details" rel="noreferrer noopener">Tilray&#8217;s Hi&#x2A;Ball Energy Returns To Whole Foods Market</a>
Gross profit was $604 million, with the margin expanding 20 basis points Y/Y to 37.6%.
Adjusted operating margin contracted 80 basis points to 14%. Adjusted EPS of $0.60 <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">missed the consensus estimate of $0.64.</a>
McCormick held $102.8 million in cash and equivalents as of February-end. The company generated an operating cash flow of $115.5 million in the quarter.
&#8220;We are pleased to start the year with solid first quarter results that are in line with our expectations, as we are managing a dynamic environment,&#8221; said President and CEO Brendan M. Foley.
Outlook Reaffirmed: McCormick sees FY25 sales growth of 0% – 2%. The company expects an adjusted EPS of <a href="https://www.benzinga.com/calendars/guidance">$3.03 – $3.08 versus an estimate of $3.07.</a>
The outlook reflects plans to offset costs related to U.S. import tariffs on&nbsp;China&nbsp;with CCI savings and targeted price adjustments.
Due to continued uncertainty regarding the implementation dates and scope of additional potential U.S. import tariffs or retaliatory tariffs put in place by other countries, this outlook does not include any additional impact from tariff actions in 2025.
Price Action: MKC shares traded lower by 3.42% at $77.60 in premarket at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44457658/clearlake-capital-acquires-data-company-dun-bradstreet-in-77b-deal" target="_blank" rel="noreferrer noopener">Dun &amp; Bradstreet To Go Private In $7.7 Billion Clearlake Deal</a></li>
</ul>
Image via Shutterstock.

Equities

Movers

Why Is Food Company McCormick Stock Trading Lower Today?

Guidance

McCormick Reaffirms FY25 Net Sales Growth Outlook Of 1% - 3% In Constant Currency

McCormick &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>) reported quarterly earnings of $0.60 per share which missed the analyst consensus estimate of $0.64 by 6.25 percent. This is a 4.76 percent decrease over earnings of $0.63 per share from the same period last year. The company reported quarterly sales of $1.60 billion which missed the analyst consensus estimate of $1.61 billion by 0.31 percent. This is a 0.12 percent increase over sales of $1.60 billion the same period last year.

Earnings

Earnings Misses

McCormick & Co Q1 Adj $0.60 Misses $0.64 Estimate, Sales $1.60B Miss $1.61B Estimate

McCormick &amp; Company, Incorporated (NYSE: MKC) will release its first-quarter financial results before the <a href="https://www.benzinga.com/quote/MKC/earnings">opening bell on Tuesday, March 25.</a>
Analysts expect the company to report quarterly earnings at 64 cents per share, up from 63 cents per share in the year-ago period. McCormick projects quarterly revenue of $1.61 billion, compared to $1.6 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Jan. 23, McCormick posted better-than-expected earnings for its fourth quarter.
McCormick shares gained 0.2% to close at $80.34 on Monday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/MKC/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>JP Morgan analyst Ken Goldman maintained an Underweight rating and raised the price target from $66 to $69 on Jan. 24, 2025. This analyst has an accuracy rate of 77%.</li>
<li>TD Cowen analyst Robert Moskow upgraded the stock from Hold to Buy and raised the price target from $86 to $90 on Jan. 8, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Jefferies analyst Rob Dickerson upgraded the stock from Hold to Buy and lifted the price target from $85 to $91 on Dec. 9, 2024. This analyst has an accuracy rate of 67%.</li>
<li>Argus Research analyst John Staszak upgraded the stock from Hold to Buy with a price target of $88 on April 2, 2024. This analyst has an accuracy rate of 68%.</li>
</ul>
Considering buying MKC stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="410" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/25045426/image-223-1024x410.png" alt="" class="wp-image-840004" style="width:561px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/25045426/image-223-1024x410.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/25045426/image-223-300x120.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/25045426/image-223-768x308.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/25045426/image-223.png 1472w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/03/44457888/top-2-financial-stocks-that-may-fall-off-a-cliff-in-march">Top 2 Financial Stocks That May Fall Off A Cliff In March</a></li>
</ul>
Image: Shutterstock

Pre-Market Outlook

McCormick Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

<h3>Companies Reporting Before The Bell</h3>
• PAVmed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAVM#NASDAQ">PAVM</a>) is expected to report earnings for its fourth quarter. 
• BiomX (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PHGE#AMEX">PHGE</a>) is projected to report earnings for its fourth quarter. 
• Sanara MedTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTI#NASDAQ">SMTI</a>) is projected to report quarterly loss at $0.19 per share on revenue of $25.90 million. 
• Cormedix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMD#NASDAQ">CRMD</a>) is projected to report quarterly earnings at $0.14 per share on revenue of $28.34 million. 
• McCormick &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>) is estimated to report quarterly earnings at $0.64 per share on revenue of $1.61 billion. 
• Super Hi International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HDL#NASDAQ">HDL</a>) is estimated to report quarterly earnings at $0.17 per share on revenue of $212.06 million. 
• Rumble (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUM#NASDAQ">RUM</a>) is likely to report quarterly loss at $0.13 per share on revenue of $30.41 million. 
• Atour Lifestyle Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATAT#NASDAQ">ATAT</a>) is estimated to report quarterly earnings at $0.30 per share on revenue of $272.21 million. 
• Canadian Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSIQ#NASDAQ">CSIQ</a>) is projected to report quarterly loss at $0.24 per share on revenue of $1.57 billion. 
• Atossa Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATOS#NASDAQ">ATOS</a>) is estimated to report earnings for its fourth quarter. 
• Verb Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERB#NASDAQ">VERB</a>) is likely to report quarterly loss at $2.52 per share on revenue of $200 thousand. 
• ACCESS Newswire (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ACCS#AMEX">ACCS</a>) is projected to report quarterly earnings at $0.23 per share on revenue of $7.38 million. 
• Nano Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NA#NASDAQ">NA</a>) is expected to report earnings for its Fiscal Year 2024. 
• 17 Education &amp; Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YQ#NASDAQ">YQ</a>) is expected to report earnings for its fourth quarter. 
• BitFuFu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUFU#NASDAQ">FUFU</a>) is projected to report quarterly loss at $0.03 per share on revenue of $99.28 million. 
• Core &amp; Main (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNM#NYSE">CNM</a>) is likely to report quarterly earnings at $0.36 per share on revenue of $1.67 billion. 
• X4 Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XFOR#NASDAQ">XFOR</a>) is projected to report quarterly loss at $0.16 per share on revenue of $1.06 million. 
• Pony AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) is expected to report earnings for its fourth quarter. 
• Viomi Technology Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIOT#NASDAQ">VIOT</a>) is likely to report earnings for its Fiscal Year 2024. 
<h3>Companies Reporting After The Bell</h3>
• Kolibri Global Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KGEI#NASDAQ">KGEI</a>) is estimated to report quarterly earnings at $0.14 per share on revenue of $17.89 million. 
• Worthington Enterprises (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOR#NYSE">WOR</a>) is expected to report quarterly earnings at $0.70 per share on revenue of $289.09 million. 
• CarParts.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTS#NASDAQ">PRTS</a>) is projected to report quarterly loss at $0.19 per share on revenue of $137.49 million. 
• Beta Bionics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBNX#NASDAQ">BBNX</a>) is projected to report quarterly loss at $0.42 per share on revenue of $20.01 million. 
• Investcorp Credit (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICMB#NASDAQ">ICMB</a>) is expected to report quarterly earnings at $0.11 per share on revenue of $5.45 million. 
• GameStop (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) is likely to report quarterly earnings at $0.08 per share on revenue of $1.48 billion. 
• Corvus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRVS#NASDAQ">CRVS</a>) is projected to report earnings for its fourth quarter. 
• ATA Creativity Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AACG#NASDAQ">AACG</a>) is expected to report earnings for its fourth quarter. 
• Noah Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOAH#NYSE">NOAH</a>) is projected to report earnings for its fourth quarter. 
• Surgepays (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SURG#NASDAQ">SURG</a>) is likely to report quarterly loss at $0.22 per share on revenue of $8.22 million. 
• GCT Semiconductor Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GCTS#NYSE">GCTS</a>) is expected to report quarterly loss at $0.15 per share on revenue of $2.03 million. 
• PaySign (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYS#NASDAQ">PAYS</a>) is expected to report quarterly earnings at $0.03 per share on revenue of $15.42 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AACG

ACCS

ATAT

ATOS

BBNX

CRMD

CRVS

CSIQ

FUFU

GCTS

ICMB

KGEI

NOAH

PAVM

PAYS

PHGE

PONY

PRTS

SMTI

SURG

VERB

VIOT

XFOR

Earnings Scheduled For March 25, 2025

McCormick &amp; Company, Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>) will release its first-quarter financial results before the <a href="https://www.benzinga.com/quote/MKC/earnings">opening bell on Tuesday, March 25.</a>
Analysts expect the company to report quarterly earnings at 64 cents per share, up from 63 cents per share in the year-ago period. McCormick projects quarterly revenue of $1.61 billion, compared to $1.6 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Jan. 27, Barclays analyst Andrew Lazar maintained McCormick with an Equal-Weight rating and lowered the price target from $85 to $82.
With the recent buzz around McCormick, some investors may be eyeing potential gains from the company's dividends, too. Currently, McCormick offers an annual dividend yield of 2.25% and a quarterly dividend of 45 cents per share ($1.80 a year).
To figure out how to earn $500 monthly from McCormick, we start with the yearly target of $6,000 ($500 x 12 months).
Next, we take this amount and divide it by McCormick's $1.80 dividend: $6,000 / $1.80 = 3,333 shares.
So, an investor would need to own approximately $267,207 worth of McCormick, or 3,333 shares, to generate a monthly dividend income of $500.
Assuming a more conservative goal of $100 monthly ($1,200 annually), we do the same calculation: $1,200 / $1.80 = 667 shares, or $53,473 to generate a monthly dividend income of $100.
Note that dividend yield can change on a rolling basis, as the dividend payment and stock price both fluctuate over time.
The dividend yield is calculated by dividing the annual dividend payment by the current stock price. As the stock price changes, the dividend yield will also change.
For example, if a stock pays an annual dividend of $2 and its current price is $50, its dividend yield would be 4%. However, if the stock price increases to $60, the dividend yield would decrease to 3.33% ($2/$60).
Conversely, if the stock price decreases to $40, the dividend yield would increase to 5% ($2/$40).
Further, the dividend payment itself can also change over time, which can also impact the dividend yield. If a company increases its dividend payment, the dividend yield will increase even if the stock price remains unchanged. Similarly, if a company decreases its dividend payment, the dividend yield will decrease.
MKC Price Action: Shares of McCormick fell by 0.7% to close at $80.17 on Friday.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44434941/how-to-earn-500-a-month-from-kb-home-stock-ahead-of-q1-earnings">How To Earn $500 A Month From KB Home Stock Ahead Of Q1 Earnings</a></li>
</ul>
Photo: Shutterstock

Long Ideas

How To Earn $500 A Month From McCormick Stock Ahead Of Q1 Earnings

Shares of consumer staples stocks are trading higher. The sector may be up amid economic uncertainty and US tariffs, which could drive a rotation into defensive stocks.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Morgan Stanley slashed the price target for Intellia Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NASDAQ">NTLA</a>) from $56 to $11. Morgan Stanley analyst Terence Flynn downgraded the stock from Overweight to Equal-Weight. Intellia Therapeutics shares closed at $10.99 on Friday. <a href="https://www.benzinga.com/quote/NTLA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays cut McCormick &amp; Company, Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>) price target from $85 to $82. Barclays analyst Andrew Lazar maintained an Equal-Weight rating. McCormick shares closed at $74.89 on Friday. <a href="https://www.benzinga.com/quote/MKC/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Barclays raised the price target for Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) from $149 to $158. Barclays analyst Matt Miksic maintained an Overweight rating. Abbott shares closed at $125.03 on Friday. <a href="https://www.benzinga.com/quote/ABT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Goldman Sachs raised the price target for Twilio Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>) from $77 to $185. Goldman Sachs analyst Kash Rangan upgraded the stock from Neutral to Buy. Twilio shares closed at $136.23 on Friday. <a href="https://www.benzinga.com/quote/TWLO/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Jefferies cut RLI Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLI#NYSE">RLI</a>) price target from $95 to $61. Jefferies analyst Andrew Andersen downgraded the stock from Buy to Underperform. RLI shares settled at $72.48 on Friday. <a href="https://www.benzinga.com/quote/RLI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley raised Exelixis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXEL#NASDAQ">EXEL</a>) price target from $30 to $40. Morgan Stanley analyst Jefferson Harralson upgraded the stock from Equal-Weight to Overweight. Exelixis shares closed at $32.38 on Friday. <a href="https://www.benzinga.com/quote/EXEL/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan decreased Omnicom Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMC#NYSE">OMC</a>) price target from $119 to $116. JP Morgan analyst David Karnovsky maintained an Overweight rating. Omnicom shares closed at $86.56 on Friday.  <a href="https://www.benzinga.com/quote/OMC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stifel raised the price target for Portillo&#8217;s Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTLO#NASDAQ">PTLO</a>) from $13 to $16. Stifel analyst Chris O&#8217;Cull upgraded the stock from Hold to Buy. Portillo&#8217;s shares settled at $12.49 on Friday. <a href="https://www.benzinga.com/quote/PTLO/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays cut RingCentral, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNG#NYSE">RNG</a>) price target from $45 to $37. Barclays analyst Ryan Macwilliams downgraded the stock from Overweight to Equal-Weight. RingCentral shares closed at $34.65 on Friday. <a href="https://www.benzinga.com/quote/RNG/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler increased Qorvo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRVO#NASDAQ">QRVO</a>) price target from $85 to $110. Piper Sandler analyst Harsh Kumar upgraded the stock from Neutral to Overweight. Qorvo shares closed at $88.94 on Friday. <a href="https://www.benzinga.com/quote/QRVO/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Read This Next:
<ul>
<li> <a href="https://www.benzinga.com/markets/25/01/43189390/top-3-materials-stocks-that-may-fall-off-a-cliff-in-january">Top 3 Materials Stocks That May Fall Off A Cliff In January</a></li>
</ul>

Price Target

EXEL

NTLA

PTLO

QRVO

TWLO

Abbott To Rally Over 26%? Here Are 10 Top Analyst Forecasts For Monday

Barclays analyst Andrew Lazar maintains McCormick &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>) with a Equal-Weight and lowers the price target from $85 to $82.

Barclays Maintains Equal-Weight on McCormick & Co, Lowers Price Target to $82

JP Morgan analyst Ken Goldman maintains McCormick &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>) with a Underweight and raises the price target from $66 to $69.

JP Morgan Maintains Underweight on McCormick & Co, Raises Price Target to $69

McCormick &amp; Co Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>) reported&nbsp;fourth-quarter sales growth of 3% year-on-year to $1.798 billion, beating the analyst consensus <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/n43155089/mccormick-reports-strong-2024-financial-results-and-provides-2025-outlook" rel="noreferrer noopener">estimate of $1.77 billion</a>.
Flavor Solutions segment sales grew by 1%, with minimal impact from currency. Consumer segment sales increased 4%.
Gross profit was $722.2 million, with the margin expanding 20 basis points Y/Y to 40.2%.
Operating income rose 3% to $306.2 million and the operating margin remained flat at 17%.
Adjusted EPS of $0.80 <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">beat the consensus estimate of $0.77.</a>
McCormick held $186.1 million in cash and equivalents as of November 30, 2024. The company generated an operating cash flow of $922 million in FY24.
&#8220;We are pleased to report strong performance for both fourth quarter and fiscal year 2024, an important year for McCormick, in which we built momentum and strengthened our leadership, returning to differentiated and sustainable volume-led growth,&#8221; said Chairman, President, and CEO Brendan M. Foley.
&#8220;Our strategic investments in core categories enabled us to drive positive volume growth, expand our margins, and deliver robust earnings growth.&#8221;
Outlook: McCormick sees FY25 sales growth of 0% – 2% as reported and 1%&nbsp;&#8211;&nbsp;3% in constant currency. The company expects an adjusted EPS of $3.03 – $3.08 versus the <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">estimate of $3.11.</a>
Price Action: MKC shares are trading higher by 2.29% at $71.55 in premarket at last check Thursday.

McCormick Posts 3% Sales Growth In Q4 As Consumer Demand Rise

McCormick Sees FY25 Adjusted EPS Of $3.03 - $3.08 Vs. $3.12 Est.

McCormick Sees FY25 Sales Growth Of 1% - 3% In Constant Currency

McCormick &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>) reported quarterly adjusted earnings of $0.80 per share which beat the analyst consensus estimate of $0.77 by 3.9 percent. This is a 5.88 percent decrease over earnings of $0.85 per share from the same period last year. The company reported quarterly sales of $1.80 billion which beat the analyst consensus estimate of $1.77 billion by 1.58 percent. This is a 2.57 percent increase over sales of $1.75 billion the same period last year.

Earnings Beats

McCormick & Co Q4 Adj $0.80 Beats $0.77 Estimate, Sales $1.80B Beat $1.77B Estimate

<h3>Companies Reporting Before The Bell</h3>
• Elevance Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELV#NYSE">ELV</a>) is estimated to report quarterly earnings at $3.86 per share on revenue of $44.72 billion. 
• Chunghwa Telecom (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHT#NYSE">CHT</a>) is projected to report earnings for its fourth quarter. 
• WNS (Hldgs) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WNS#NYSE">WNS</a>) is likely to report quarterly earnings at $1.04 per share on revenue of $332.22 million. 
• Pacific Premier Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPBI#NASDAQ">PPBI</a>) is likely to report quarterly earnings at $0.31 per share on revenue of $142.92 million. 
• OSI Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSIS#NASDAQ">OSIS</a>) is expected to report quarterly earnings at $2.33 per share on revenue of $406.61 million. 
• Union Pacific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNP#NYSE">UNP</a>) is expected to report quarterly earnings at $2.78 per share on revenue of $6.15 billion. 
• Texas Capital Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBI#NASDAQ">TCBI</a>) is projected to report quarterly earnings at $1.08 per share on revenue of $283.78 million. 
• Old Republic Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORI#NYSE">ORI</a>) is projected to report quarterly earnings at $0.69 per share on revenue of $2.11 billion. 
• West Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTBA#NASDAQ">WTBA</a>) is expected to report quarterly earnings at $0.40 per share on revenue of $21.42 million. 
• Valley Ntl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VLY#NASDAQ">VLY</a>) is estimated to report quarterly earnings at $0.14 per share on revenue of $467.97 million. 
• MarineMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>) is projected to report quarterly loss at $0.18 per share on revenue of $485.52 million. 
• First BanCorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FBP#NYSE">FBP</a>) is likely to report quarterly earnings at $0.41 per share on revenue of $236.55 million. 
• Novagold Resources (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NG#AMEX">NG</a>) is estimated to report earnings for its fourth quarter. 
• Northern Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRS#NASDAQ">NTRS</a>) is estimated to report quarterly earnings at $2.00 per share on revenue of $1.93 billion. 
• Dr Reddy's Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDY#NYSE">RDY</a>) is estimated to report quarterly earnings at $0.19 per share on revenue of $964.48 million. 
• Amalgamated Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAL#NASDAQ">AMAL</a>) is estimated to report quarterly earnings at $0.87 per share on revenue of $81.90 million. 
• MakeMyTrip (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>) is likely to report quarterly earnings at $0.45 per share on revenue of $264.99 million. 
• Heritage Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HFWA#NASDAQ">HFWA</a>) is expected to report quarterly earnings at $0.44 per share on revenue of $60.71 million. 
• Dime Community Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCOM#NASDAQ">DCOM</a>) is likely to report quarterly earnings at $0.45 per share on revenue of $62.64 million. 
• McCormick &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>) is expected to report quarterly earnings at $0.77 per share on revenue of $1.77 billion. 
• American Airlines Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) is projected to report quarterly earnings at $0.39 per share on revenue of $13.13 billion. 
• TAL Education (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAL#NYSE">TAL</a>) is expected to report quarterly earnings at $0.06 per share on revenue of $539.86 million. 
• Global X Guru Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GURU#NYSE">GURU</a>) is projected to report quarterly loss at $0.09 per share on revenue of $7.55 million. 
• LSI Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYTS#NASDAQ">LYTS</a>) is estimated to report quarterly earnings at $0.20 per share on revenue of $129.20 million. 
• GATX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GATX#NYSE">GATX</a>) is likely to report quarterly earnings at $1.78 per share on revenue of $399.00 million. 
• Independent Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBCP#NASDAQ">IBCP</a>) is estimated to report quarterly earnings at $0.76 per share on revenue of $48.94 million. 
• Freeport-McMoRan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>) is projected to report quarterly earnings at $0.35 per share on revenue of $6.27 billion. 
• Banc of California (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BANC#NYSE">BANC</a>) is expected to report quarterly earnings at $0.23 per share on revenue of $272.18 million. 
• GE Aero (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) is likely to report quarterly earnings at $1.05 per share on revenue of $9.84 billion. 
• Atlantic Union Bankshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AUB#NYSE">AUB</a>) is estimated to report quarterly earnings at $0.79 per share on revenue of $222.26 million. 
<h3>Companies Reporting After The Bell</h3>
• Texas Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) is projected to report quarterly earnings at $1.20 per share on revenue of $3.87 billion. 
• Covenant Logistics Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVLG#NYSE">CVLG</a>) is expected to report quarterly earnings at $0.50 per share on revenue of $284.91 million. 
• OceanFirst Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCFC#NASDAQ">OCFC</a>) is projected to report quarterly earnings at $0.36 per share on revenue of $94.95 million. 
• First Western Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYFW#NASDAQ">MYFW</a>) is expected to report quarterly earnings at $0.26 per share on revenue of $24.41 million. 
• SouthState (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSB#NYSE">SSB</a>) is expected to report quarterly earnings at $1.73 per share on revenue of $434.57 million. 
• Five Point Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FPH#NYSE">FPH</a>) is likely to report earnings for its fourth quarter. 
• USCB Financial Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USCB#NASDAQ">USCB</a>) is expected to report quarterly earnings at $0.37 per share on revenue of $22.41 million. 
• First Financial Bancor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFBC#NASDAQ">FFBC</a>) is projected to report quarterly earnings at $0.65 per share on revenue of $216.32 million. 
• First Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRBA#NASDAQ">FRBA</a>) is estimated to report quarterly earnings at $0.39 per share on revenue of $32.84 million. 
• SLM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLM#NASDAQ">SLM</a>) is expected to report quarterly earnings at $0.56 per share on revenue of $371.74 million. 
• MidWestOne Financial Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOFG#NASDAQ">MOFG</a>) is estimated to report quarterly earnings at $0.72 per share on revenue of $57.00 million. 
• Midland States Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSBI#NASDAQ">MSBI</a>) is likely to report quarterly earnings at $0.67 per share on revenue of $73.57 million. 
• Metropolitan Bank Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCB#NYSE">MCB</a>) is estimated to report quarterly earnings at $1.49 per share on revenue of $67.43 million. 
• Customers Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CUBI#NYSE">CUBI</a>) is estimated to report quarterly earnings at $1.20 per share on revenue of $164.07 million. 
• East West Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>) is expected to report quarterly earnings at $2.12 per share on revenue of $659.00 million. 
• Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) is estimated to report quarterly earnings at $1.75 per share on revenue of $2.20 billion. 
• Glacier Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBCI#NYSE">GBCI</a>) is projected to report quarterly earnings at $0.52 per share on revenue of $224.99 million. 
• Business First Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFST#NASDAQ">BFST</a>) is likely to report quarterly earnings at $0.49 per share on revenue of $75.13 million. 
• SB Finl Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBFG#NASDAQ">SBFG</a>) is expected to report quarterly earnings at $0.41 per share on revenue of $10.20 million. 
• Byline Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BY#NYSE">BY</a>) is projected to report quarterly earnings at $0.61 per share on revenue of $100.39 million. 
• Eastern Bankshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBC#NASDAQ">EBC</a>) is projected to report quarterly earnings at $0.34 per share on revenue of $184.71 million. 
• 1st Source (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRCE#NASDAQ">SRCE</a>) is likely to report quarterly earnings at $1.33 per share on revenue of $97.65 million. 
• Associated Banc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASB#NYSE">ASB</a>) is likely to report quarterly earnings at $0.52 per share on revenue of $337.81 million. 
• Columbia Banking System (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COLB#NASDAQ">COLB</a>) is projected to report quarterly earnings at $0.66 per share on revenue of $489.74 million. 
• CSX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSX#NASDAQ">CSX</a>) is likely to report quarterly earnings at $0.44 per share on revenue of $3.61 billion. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMAL

BANC

BFST

COLB

CUBI

CVLG

DCOM

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

EWBC

FFBC

FRBA

GATX

GBCI

GURU

HFWA

IBCP

ISRG

LYTS

MMYT

MOFG

MSBI

MYFW

NTRS

OCFC

OSIS

PPBI

SBFG

SRCE

TCBI

USCB

WTBA

Earnings Scheduled For January 23, 2025

McCormick &amp; Company, Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>) will release its fourth-quarter financial results, before the <a href="https://www.benzinga.com/quote/MKC/earnings">opening bell, on Thursday, Jan. 23, 2025.</a>
Analysts expect the Hunt Valley, Maryland-based company to report quarterly earnings at 77 cents per share, down from 85 cents per share in the year-ago period. McCormick projects quarterly revenue of $1.77 billion, compared to $1.75 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Nov. 19, 2024, McCormick raised its quarterly dividend from 42 cents to 45 cents per share on its common stock.
McCormick shares fell 1.4% to close at $73.24 on Wednesday&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; .
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/MKC/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>JP Morgan analyst Ken Goldman maintained an Underweight rating and cut the price target from $68 to $66 on Jan. 15, 2025. This analyst has an accuracy rate of 76%.</li>
<li>TD Cowen analyst Robert Moskow upgraded the stock from Hold to Buy and raised the price target from $86 to $90 on Jan. 8, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Jefferies analyst Rob Dickerson upgraded the stock from Hold to Buy and raised the price target from $85 to $91 on Dec. 9, 2024. This analyst has an accuracy rate of 68%.</li>
<li>Argus Research analyst John Staszak upgraded the stock from Hold to Buy with a price target of $88 on April 2, 2024. This analyst has an accuracy rate of 68%.</li>
</ul>
Considering buying MKC stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="579" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23025203/image-159-1024x579.png" alt="" class="wp-image-746235" style="width:460px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23025203/image-159-1024x579.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23025203/image-159-300x170.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23025203/image-159-768x435.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23025203/image-159.png 1117w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43126364/jim-cramer-this-tech-stock-is-a-buy-amd-is-a-great-company">Jim Cramer: AMD Is A &#8216;Great&#8217; Company, Hold Onto Dow Inc.</a></li>
</ul>

McCormick Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Press Releases

McCORMICK REPORTS STRONG 2024 FINANCIAL RESULTS AND PROVIDES 2025 OUTLOOK

McCormick & Company to Present at Consumer Analyst Group of New York Conference

Holladay Distillery breaks ground on ironclad rickhouse in latest growth spurt

McCormick & Company to Report 2025 First Quarter Financial Results on March 25, 2025

McCORMICK REPORTS SOLID FIRST QUARTER PERFORMANCE AND REAFFIRMS 2025 OUTLOOK

Dividends

McCormick Declares $0.45 Quarterly Dividend

McCormick Honors 2025 Unsung Heroes; Awards $105,000 in Total Scholarships to Student-Athletes

McCormick & Company to Participate in Deutsche Bank's Annual dbAccess Global Consumer Conference

McCormick Announces Kasey Jenkins' Plan to Retire

McCormick & Company to Report 2025 Second Quarter Financial Results on June 26, 2025

Comments

McCormick & Co

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL